Stocktoria

ORTHOPEDIATRICS CORP KIDS

Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus
Chart by TradingView
4/9
Piotroski F — financial health
2.67
Altman Z″ — distress risk · safe
Dividend payout · no dividend

Financials (annual, from 10-K)

FYRevenueNet incomeGross profitFree cash flowEquity
2025$236.3M-$39.6M$172.7M-$16.0M$346.6M
2024$204.7M-$37.8M$148.6M-$41.3M$354.6M
2023$148.7M-$21.0M$111.3M-$43.9M$377.0M
2022$122.3M$1.3M$90.7M-$31.8M$378.6M
2021$98.0M-$16.3M$73.4M-$21.2M$225.4M
2020$71.1M-$32.9M$55.0M-$29.0M$234.8M

Recent insider activity (Form 4)

InsiderRoleDateActionSharesPrice
Pelizzon David Rdirector2026-06-09Grant11,436
Hughes Bryan Wdirector2026-06-09Grant11,436
Fischer Kelly Lainedirector2026-06-09Grant11,436
Riccitelli Samuel Ddirector2026-06-09Grant11,436
Ruf Harolddirector2026-06-09Grant11,436
Bailey David RPresident and CEO2026-06-09Grant119,140
McDonald Jimmy Duanedirector2026-06-09Grant11,436
Infante (Reynolds) Marie Cdirector2026-06-09Grant11,436

Why these scores methodology →

Piotroski F-score: 4/9

  • Positive return on assets
  • Positive operating cash flow
  • Rising ROA
  • Cash flow exceeds net income
  • Lower long-term debt
  • Rising current ratio
  • No share dilution
  • Rising gross margin
  • Rising asset turnover

Altman Z″: 2.67 (safe)

  • Working capital / assets 0.413
  • Retained earnings / assets -0.541
  • EBIT / assets -0.077
  • Equity / liabilities 2.139

Source: SEC EDGAR filings · CIK 0001425450 · as of 2025-12-31. Figures are facts from filings plus Stocktoria's own computed scores — not investment advice.